Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
It´s the first trial to demonstrate the benefits of dual pathway inhibition
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Voluntary nationwide recall of lots of Accuretic (quinapril HCl/hydrochlorothiazide), quinapril and hydrochlorothiazide tablets, and quinapril HCl/hydrochlorothiazide tablets due to n-nitroso- quinapril content
Subscribe To Our Newsletter & Stay Updated
